药品:专业
阿根廷公司从事该行业的公司：药品:专业
下面的列表包含在同一行业，药品:专业下运营的阿根廷公司。该列表有助于跟踪他们的表现、损益表等。按任何必要的指标排序，它可以显示行业中最贵的股票，例如ASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25，或具有最佳价格动态的股票，例如NOVARTIS AG CEDEAR EAC 4 REP 1(USD)，从而有助于设计任何重点策略。
商品代码 | 市值 | 价格 | 涨跌 % | 成交量 | 相对交易量 | P/E | 摊薄每股收益 净利率，TTM | 每股收益缓慢增长 TTM同比 | 股息收益率 % 净利率，TTM | 板块 | 分析师评级 |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1DR | 618.653 T ARS | 14037.500 ARS | +1.33% | 1.105 K | 0.54 | — | — | — | — | 健康科技 | — |
| LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD) DR | 618.653 T ARS | 13.200 USD | 0.00% | 14 | 0.15 | — | — | — | — | 健康科技 | — |
 JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHSDR | 314.491 T ARS | 10527.500 ARS | +0.01% | 5.521 K | 0.35 | 43.34 | 242.90 ARS | +459.57% | 0.87% | 健康科技 | — |
| DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 314.491 T ARS | 1160.000 ARS | −0.68% | 35 | 0.00 | — | — | — | — | 健康科技 | — |
| JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD) DR | 314.491 T ARS | 10.550 USD | −2.31% | 453 | 0.56 | 37.19 | 242.90 ARS | +48.88% | 0.87% | 健康科技 | — |
 MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50)DR | 280.403 T ARS | 26730.500 ARS | −0.79% | 464 | 0.70 | — | — | — | — | 健康科技 | — |
| MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD) DR | 280.403 T ARS | 27.150 USD | +4.42% | 28 | 4.24 | — | — | — | — | 健康科技 | — |
 ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COMDR | 261.951 T ARS | 17898.500 ARS | +0.46% | 695 | 0.32 | 22.30 | 802.79 ARS | −6.12% | 0.99% | 健康科技 | — |
| ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD) DR | 261.951 T ARS | 17.900 USD | +3.17% | 10 | 0.10 | 18.03 | 802.79 ARS | −77.92% | 0.99% | 健康科技 | — |
 AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25DR | 189.694 T ARS | 37300.500 ARS | +0.26% | 330 | 0.30 | 179.35 | 207.98 ARS | +257.80% | 1.14% | 健康科技 | — |
| AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD) DR | 189.694 T ARS | 36.750 USD | 0.00% | 1 | 0.13 | 142.85 | 207.98 ARS | −15.86% | 1.14% | 健康科技 | — |
 NVSNOVARTIS AG CEDEAR EACH 4 REP 1DR | 168.425 T ARS | 25619.500 ARS | +0.87% | 299 | 5.17 | — | — | — | — | 健康科技 | — |
| NVSDNOVARTIS AG CEDEAR EAC 4 REP 1(USD) DR | 168.425 T ARS | 24.250 USD | +4.98% | 2 | 0.34 | — | — | — | — | 健康科技 | — |
 PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05DR | 129.689 T ARS | 6933.500 ARS | −0.71% | 8.955 K | 0.38 | — | — | — | — | 健康科技 | — |
| PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD) DR | 129.689 T ARS | 6.960 USD | +0.87% | 1.814 K | 2.87 | — | — | — | — | 健康科技 | — |
 AMGNAMGEN INC CEDEAR EACH 30 REP 1DR | 127.919 T ARS | 9619.000 ARS | +0.09% | 887 | 0.74 | — | — | — | — | 健康科技 | — |
| AMGNDAMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD) DR | 127.919 T ARS | 9.780 USD | +0.31% | 31 | 0.56 | — | — | — | — | 健康科技 | — |
 BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1DR | 86.641 T ARS | 17202.000 ARS | −0.98% | 266 | 0.77 | — | — | — | — | 健康科技 | — |
| BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 86.641 T ARS | 17.000 USD | −2.86% | 6 | 1.20 | — | — | — | — | 健康科技 | — |
 GSKGSK PLC CEDEAR EACH REPR 1/4 ADRDR | 73.887 T ARS | 10835.000 ARS | +0.72% | 425 | 1.94 | 55.76 | 194.30 ARS | −31.41% | 1.37% | 健康科技 | — |
| GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD) DR | 73.887 T ARS | 10.300 USD | +0.98% | 7 | 0.24 | 42.85 | 194.30 ARS | −83.87% | 1.37% | 健康科技 | — |
 BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005DR | 24.503 T ARS | 15674.500 ARS | −0.82% | 211 | 0.46 | — | — | — | — | 健康科技 | — |
| BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD) DR | 24.503 T ARS | 16.250 USD | −18.75% | 20 | 2.47 | — | — | — | — | 健康科技 | — |
 RICHLABORATORIOS RICHMOND SACIF | 71.667 B ARS | 887.500 ARS | +0.80% | 3.413 K | 0.55 | — | −130.78 ARS | — | 0.00% | 健康科技 | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 3.896 B ARS | 91.500 ARS | −0.11% | 261 | 0.06 | — | — | — | 0.00% | 健康科技 | — |